about
Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primateAtenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms.Drug Interactions at the Human Placenta: What is the Evidence?Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primateRapid solid-phase extraction method to quantify [(11)C]-verapamil, and its [(11)C]-metabolites, in human and macaque plasma.Evaluation of Near Infrared Dyes as Markers of P-Glycoprotein Activity in TumorsPharmacokinetics of doxorubicin in pregnant women.The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension.Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria.Antiepileptic drugs alter the expression of placental carriers: An in vitro study in a human placental cell line.Imaging transporters: Transforming diagnostic and therapeutic development.Effects of valproic acid on the placental barrier in the pregnant mouse: Optical imaging and transporter expression studies.Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.Utilization of antiepileptic drugs in Israel.An evaluation of pharmacist knowledge on treatment with antiepileptic drugs.Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives.Use of antiepileptic drugs during pregnancy and lactation: Type of information provided by searching Google.Pharmacokinetics of metoprolol during pregnancy and lactation.Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging.The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants.Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs.The activity of antiepileptic drugs as histone deacetylase inhibitors.Evaluation of the near infrared compound indocyanine green as a probe substrate of p-glycoprotein.Tracking inflammation in the epileptic rat brain by bi-functional fluorescent and magnetic nanoparticles.Intraoperative Localization of Rectal Tumors Using Liposomal Indocyanine Green.Maternal-fetal transfer of indocyanine green across the perfused human placenta.Imaging the urinary pathways in mice by liposomal indocyanine green.Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment.The Placental Barrier: the Gate and the Fate in Drug Distribution.The Fever Tree: from Malaria to Neurological DiseasesGenetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab PopulationsUse of Therapeutics in Pregnancy and LactationCausative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in IsraelThe Effects of Central Nervous System-Active Valproic Acid Constitutional Isomers, Cyclopropyl Analogs, and Amide Derivatives on Neuronal Growth Cone BehaviorOne Giant Leap for Pharmacology
P50
Q33673118-C12FE784-81A2-497B-B79B-303ABEE04F23Q34134437-F8BB5090-CB12-41B4-9F52-9DBD1F91CC28Q35768413-24147B8B-C1FE-4BD6-BFA0-E6F75035C205Q35781798-0A9F8F4F-8B1F-46D6-AE45-33882D635678Q36081992-1929E806-4D9A-444A-ADAB-4978A3BC6618Q36404535-B7B226B6-035D-4263-9DCF-A82EA52EB634Q37244471-9C9C7FE9-681C-40F4-A942-981C0ABE2D4FQ37339744-AF028E3B-12A6-4D0A-8D6D-71FC3C83FBB6Q37413413-2EA98497-9D78-495B-9EFE-0C3904E6BB06Q37695910-220B5209-08E0-456C-A030-25AD70DB9D95Q38156301-91288C28-8BF8-4C32-B733-8B351F3DD784Q38794104-14BC0F3C-D181-4C38-9112-41500F0CD461Q38868683-81D68CEA-1314-4F1C-9355-CA53F7CA042EQ38871905-42480904-35C3-41BE-A48C-2E9CA0681681Q38871992-D96E4E3B-938F-4A47-ABD6-A246BA958F87Q39487785-760336BF-963D-485A-8500-A7BBB337341AQ39654843-B45AD135-BD93-4965-821E-377E6D46ADBAQ40145167-1039A7FF-E01E-4A12-AC11-E709AD57A31DQ40429957-7A4726F9-1282-424B-AAAA-781A70E27E8AQ40973100-2A322FDC-7D3D-48B4-B944-9D81CB2EFBDDQ41470697-D8FA7542-956B-4BFF-99D9-2C0E6FA863DDQ43020712-21CA1B4D-82B0-47CE-AA52-DE724921DDE2Q43282541-7E5EAB78-80B4-41F4-AF8B-7B6414DA2D56Q44018627-C0186D32-9732-41B3-9238-52607F5B5A1EQ44315138-80C4E42C-A78A-44D0-8330-85FCBB7C5FCFQ44961269-D8F6C7B5-D391-4080-B672-FEDDF5CF6D29Q48321224-D3EDE5AA-D58D-452B-ABB1-626B97F53F49Q48624442-237230C5-F94D-45BF-BC2D-CB448B6FCBB1Q50209045-BCC31706-BB45-4A12-BB33-AC3EDA0231D9Q50228771-FB4E9787-E967-4454-8099-9DFAFA9DB3C3Q50437844-F4509392-E73A-4170-B864-7D33981F76BEQ50755741-F9E493F3-2C63-4A37-8D6F-8360B4827A8AQ51114293-BAFBB1D9-B670-43EB-B4CD-29F6EA17BCCCQ52687627-CBDD54D9-3B32-432B-BE33-87AD7A6EB7B3Q60949789-401A3486-AE4B-4358-A3C6-6314D122CE7AQ61639626-6E7F8BEA-4CE3-4834-AB78-F670814F532CQ61639630-0FF7ADB0-738D-4F85-A7FD-B9C652DC0552Q61639636-A1960C48-D7F9-4241-A479-8003F2B7CEBEQ61639694-B9984712-2E4C-4509-95BD-58E52297F2ECQ89986296-40545E87-44EA-4C4C-9E8E-22099AF32099
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara Eyal
@ast
Sara Eyal
@en
Sara Eyal
@es
Sara Eyal
@nl
Sara Eyal
@sl
type
label
Sara Eyal
@ast
Sara Eyal
@en
Sara Eyal
@es
Sara Eyal
@nl
Sara Eyal
@sl
prefLabel
Sara Eyal
@ast
Sara Eyal
@en
Sara Eyal
@es
Sara Eyal
@nl
Sara Eyal
@sl
P106
P21
P31
P496
0000-0003-1275-6094